Nasdaq Earnings Preview: Options Hedging Rises as Insiders Cash Out
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
NDAQ reports Q3 results this morning with options traders more defensive than they have been in months, even as the stock finally caught up with its peer group over the past week.
The clearest positioning signal is in the options market. The put/call ratio climbed to 0.66, roughly 1.5 standard deviations above its 20-day average of 0.50. That is not an extreme reading by absolute standards, but it marks a sustained shift: the ratio has held above 0.65 for three consecutive sessions after spending much of September below 0.50. The borrow market adds no pressure to this picture. Availability is essentially unlimited, with shares available to lend running at multiples of current short demand. Short interest is 1.4% of the float, and borrowing costs dropped to 0.17% on October 20, the lowest reading in the 30-day window. There is no short-squeeze story here.
The analyst community is broadly positive but trimming expectations ahead of the print. Morgan Stanley kept its Overweight rating while cutting its target from $120 to $118 earlier this month. Barclays and TD Cowen made similar moves, each maintaining positive ratings while nudging targets lower. Piper Sandler went the other way, raising its target to $108 from $104. The mean target now stands at $108.75, implying roughly 13% upside to the $96.12 close. Wells Fargo initiated coverage at Equal-Weight with a $100 target, adding a neutral voice to what remains a predominantly bullish consensus. Bears point to a projected 10% decline in FY26 EPS, weak IPO volumes, and integration risk from the Adenza acquisition. Bulls counter with a 14% year-over-year gain in Market Services revenue and a 25% jump in Financial Crime Management Technology, alongside the cross-selling opportunity that Adenza brings.
Insider activity has been one-sided. Net sales over the past 90 days totalled roughly $5.5 million across 10 transactions, with the President of Capital Access Platforms accounting for the largest individual trades. Several of the sales were conducted under pre-arranged 10b5-1 plans, which reduces their signal value, but the direction has been consistent: no open-market purchases appear in the recent record. One item worth flagging from the 13D/G register: Argus Seller, LP filed a Schedule 13D/A in May 2025, the activist form, disclosing a 4.44% stake. That stake has since fallen below the 5% reporting threshold with no further filing, so the current position is unknown. As with all Schedule 13D/G disclosures, the figure is as-last-reported and may no longer reflect the holder's actual position.
The print will test whether the acceleration in Financial Technology revenue is durable enough to offset the EPS headwind that has prompted the recent round of target cuts.
Stocks in this article
See the live data behind this article on ORTEX.
Open NDAQ on ORTEX →How this article was generated
- Generated
- 22 Oct 2026, 04:14
- Data as of
- 22 Oct 2026, 04:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.